HEPATOSPLENIC T-CELL LYMPHOMA

This adverse event was reported 371 times

These drugs are most commonly taken by patients reporting HEPATOSPLENIC T-CELL LYMPHOMA:

# Drug Count
0 INFLIXIMAB 184
1 AZATHIOPRINE 155
2 PREDNISONE 90
3 METHOTREXATE SODIUM 89
4 ADALIMUMAB 76
5 METHOTREXATE 74
6 MERCAPTOPURINE 71
7 ETOPOSIDE 64
8 TACROLIMUS 59
9 TACROLIMUS EXTENDED-RELEASE CAPSULES 59
See all common drugs associated with HEPATOSPLENIC T-CELL LYMPHOMA

HEPATOSPLENIC T-CELL LYMPHOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 HUMAN GROWTH HORMONE 2 0.0286
1 PRALATREXATE 7 0.0108
2 AURANOFIN 1 0.0049
3 AZATHIOPRINE SODIUM 12 0.0047
4 NELARABINE 4 0.0041
5 MERCAPTOPURINE 71 0.0041
6 ANAKINRA 48 0.0028
7 ACETAZOLAMIDE SODIUM 15 0.0024
8 BALSALAZIDE DISODIUM 1 0.0019
9 PENTOSTATIN 2 0.0019
See all drugs enriched for association with HEPATOSPLENIC T-CELL LYMPHOMA